Vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma (ViP): a prospective, randomised, double-blind, multicentre phase 2 trial
Phase Ib Study of PEGylated Recombinant Human Hyaluronidase and Gemcitabine in Patients with Advanced Pancreatic Cancer
Tags: antimetabolite, cancer, chemotherapy, Gemzar®, pyrimidine nucleoside prodrug, ribonucleotide reductase inhibitor
BASi Method Number SAP.1849
Sign up and you’ll receive the latest updates that matter to you, delivered straight to your inbox.
